跳至主要内容
临床试验/NCT03986580
NCT03986580进行中(未招募)不适用

Prospective Evaluation Of Lumbar Discectomy With Additional Implantation Of An Annular Closure Device In Patients With Large Postsurgical Annular Defects For Prevention Of Lumbar Disc Reherniation

Intrinsic Therapeutics14 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2020年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
55
试验地点
14
主要终点
Hospital readmission occurrence

研究概览

简要总结

The purpose of this prospective, single-arm, multicenter study is to assess an annular closure device when used as an adjunct to a primary lumbar limited discectomy, to limited discectomy alone.

详细描述

This single-arm case series will enroll 75 patients at select US (approximately 8-10) sites. Patients that are scheduled for a single-level L4-S1 discectomy and who meet the pre-operative eligibility criteria will be considered for study participation. Patients that meet all intraoperative criteria will be enrolled into the study and treated with lumbar discectomy and additional annular closure device implantation. All enrolled subjects will be followed for at least 12 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 to 75 years old and skeletally mature (male or female)
  • Subjects with posterior or posterolateral disc herniations at one level between L4 and S1 with radiographic confirmation of neural compression using MRI. [Note: Intraoperatively, only patients with an anular defect (post discectomy) between 4mm and 6mm tall and 6mm and 10mm wide shall qualify.]
  • At least six (6) weeks of failed, conservative treatment prior to surgery, including physical therapy, use of anti-inflammatory medications at maximum specified dosage and/or administration of epidural/facet injections.;
  • Minimum posterior disc height of 5mm at the index level.
  • Radiculopathy (with or without back pain) with a positive Straight Leg Raise (0 - 60 degrees)
  • Oswestry Questionnaire score of at least 40/100 at baseline.
  • VAS leg pain (one or both legs) of at least 40/100 at baseline.
  • Psychosocially, mentally and physically able to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements.

排除标准

  • Spondylolisthesis Grade II or higher (25% slip or greater).
  • Subject requires spinal surgery other than a discectomy (with or without laminotomy) to treat leg/back pain (scar tissue and osteophyte removal is allowed).
  • Subject has back or non-radicular leg pain of unknown etiology.
  • Prior surgery at the index lumbar vertebral level
  • Subject requiring a spine DEXA (i.e., patients with SCORE of ≥ 6) with a T Score less than -2.0 at the index level. For patients with a herniation at L5/S1, the average T score of L1-L4 shall be used.
  • Subject has clinically compromised vertebral bodies in the lumbosacral region due to any traumatic, neoplastic, metabolic, or infectious pathology.
  • Subject has sustained pathologic fractures of the vertebra or multiple fractures of the vertebra or hip
  • Subject has scoliosis of greater than ten (10) degrees (both angular and rotational).
  • Any metabolic bone disease.
  • Subject has an active infection either systemic or local.
  • Subject has cauda equina syndrome or neurogenic bowel/bladder dysfunction.
  • Subject has severe arterial insufficiency of the legs or other peripheral vascular disease. (Screening on physical examination for patients with diminution or absence of dorsalis pedis or posterior tibialis pulses. If diminished or absent by palpation, then an arterial ultrasound is required with vascular plethysmography. If the absolute arterial pressure is below 50mm of Hg at the calf or ankle level, then the patient is to be excluded.)
  • Subject has significant peripheral neuropathy, defined as a subject with Type I or Type II diabetes or similar systemic metabolic condition causing decreased sensation in a stocking-like or non-radicular and non-dermatomal distribution in the lower extremities.
  • Subject has insulin-dependent diabetes mellitus.
  • Subject is morbidly obese (defined as a body mass index >40, or weighs more than 100 lbs over ideal body weight).
  • Subject has been diagnosed with active hepatitis, AIDS, or HIV.
  • Subject has been diagnosed with rheumatoid arthritis or other autoimmune disease.
  • Subject has a known allergy to titanium, polyethylene or polyester materials.
  • Any subject that cannot have a baseline MRI taken.
  • Subject is pregnant or interested in becoming pregnant in the next 2 years.
  • Subject has active tuberculosis or has had tuberculosis in the past three (3) years.
  • Subject has a history of active malignancy: A subject with a history of any invasive malignancy (except non-melanoma skin cancer), unless he/she has been treated with curative intent and there have been no signs or symptoms of the malignancy for at least two (2) years.
  • Subject is immunologically suppressed, received steroids >1 month over the past year.
  • Currently taking anticoagulants, other than aspirin, unless the patient can be taken off the anticoagulant for surgery.
  • Subject has a current chemical/alcohol dependency or significant psychosocial disturbance.
  • Subject has a life expectancy of less than three (3) years.
  • Subject is currently involved in active spinal litigation.
  • Subject is currently involved in another investigational study.
  • Subject is incarcerated.
  • Any contraindication for MRI (e.g. claustrophobia, contrast allergy).

结局指标

主要结局

Hospital readmission occurrence

时间窗: Post-procedure hospital discharge day (in average between 1 and 3 days post surgery), 4 Weeks, 3 Months, 1 year

Change from baseline in incidence of re-admissions to hospital, post treatment

Procedure time

时间窗: Intra-operative

Length of surgery, measured in minutes

ODI

时间窗: Baseline, 4 Weeks, 3 Months, 1 year

Change from baseline in Oswestry Disability Index. The ODI is scored on a scale from 0% to 100%, with higher scores indicating higher levels of disability

Neurological assessment

时间窗: Baseline, 4 Weeks, 3 Months, 1 year

Change from baseline in sensory (sensation response at dermatomal levels) reflex, (knee jerk, ankle jerk, response measured as "normal", "increased", "absent" and "decreased") and muscle strength measured 0-5 with "0" representing no evidence of motor strength and "5" representing full resistance

Leg pain severity (0-100 VAS score)

时间窗: Baseline, 4 Weeks, 3 Months, 1 year

Change from baseline of Visual Analogue Scale score (values between 0-100), with lower values representing better outcome

Satisfaction with surgery procedure

时间窗: 1 year

Patient satisfaction with surgery and treatment assessed utilizing questionnaire with Composite questionnaire with 2 questions will be administered; 1.) Indicate degree of satisfaction with the outcome and 2.) likelihood of recommending the procedure to others

Adverse events

时间窗: Baseline, Intra-operative, 4 Weeks, 3 Months, 1 year

Change of health status with occurrence of adverse event, reported by seriousness and relationship to the device or procedure

Blood loss

时间窗: Intra-operative

Amount of blood loss measured in ml

Hospital stay

时间窗: Post-procedure hospital discharge day (in average between 1 and 3 days post surgery)

Length of the hospital stay measured in days between hospital admission and hospital discharge

Back pain severity (0-100 VAS score)

时间窗: Baseline, 4 Weeks, 3 Months, 1 year

Change from baseline of Visual Analogue Scale score (values between 0-100), with lower values representing better outcome

EQ-5D

时间窗: Baseline, 4 Weeks, 3 Months, 1 year

Change from baseline in EQ-5D. The EuroQol (EQ-5D) is a generic utility measure used to characterize current health states. The subject-reported questionnaire consists of 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each of which can take one of three responses. Possible responses include three levels of severity (no problems/some or moderate problems/extreme problems) within a particular EQ-5D dimension

Reoperation incidence

时间窗: Post-procedure hospital discharge day (in average between 1 and 3 days post surgery), 4 Weeks, 3 Months, 1 year

Change from baseline in incidence of post-operative reoperation at the index level

Return to work assessment

时间窗: 4 Weeks, 3 Months, 1 year

Change from baseline in work status (ability to return to work, with or without reported restrictions)

Discharge status

时间窗: Post-procedure hospital discharge day (in average between 1 and 3 days post surgery)

Evaluation of improvement in motor and sensory neurologic status

Symptomatic reherniation incidence

时间窗: Post-procedure hospital discharge day (in average between 1 and 3 days post surgery), 4 Weeks, 3 Months, 1 year

Change from baseline in incidence of post-operative recurrent herniation at the index level. Recurrent herniation may be confirmed surgically, or radiographically as determined by an independent review

Opioid consumption

时间窗: Baseline, Intra-operative, Post-procedure hospital discharge day (in average between 1 and 3 days post surgery), 4 Weeks, 3 Months, 1 year

Change from baseline for all opioid based medications (routes of administration (oral, IV, transdermal), dosing (mg/ml/tablet), duration (days)).

次要结局

未报告次要终点

研究者

发起方
Intrinsic Therapeutics
申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验

Study of Lumbar Discectomy With Annular Closure | 临床试验